NeuroThera Labs receives conditional approval for CliniQuantum acquisition

May 28, 2026 8:40 AM

NeuroThera Labs Inc. (TSXV: NTLX) received conditional regulatory approval from the TSX Venture Exchange for its acquisition of approximately 54 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found